Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 0 | $0 |
Sells | 656 | $429,496,815 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
05 Jul 2022 16:03 | REGN | REGENERON PHARMACEUTICALS Inc | MCCOURT MARION | EVP Commercial | 01 Jul 2022 | Sale | 1,100 | 587.76 | 646,536 | D |
02 Aug 2022 16:28 | REGN | REGENERON PHARMACEUTICALS Inc | MCCOURT MARION | EVP Commercial | 01 Aug 2022 | Sale | 1,100 | 581.53 | 639,683 | D |
08 Aug 2022 16:11 | REGN | REGENERON PHARMACEUTICALS Inc | STAHL NEIL | EVP Research and Development | 05 Aug 2022 | Sale | 100 | 621.11 | 62,111 | D |
08 Aug 2022 16:11 | REGN | REGENERON PHARMACEUTICALS Inc | STAHL NEIL | EVP Research and Development | 05 Aug 2022 | Sale | 177 | 620.11 | 109,759 | D |
08 Aug 2022 16:11 | REGN | REGENERON PHARMACEUTICALS Inc | STAHL NEIL | EVP Research and Development | 05 Aug 2022 | Sale | 502 | 619.64 | 311,059 | D |
08 Aug 2022 16:11 | REGN | REGENERON PHARMACEUTICALS Inc | STAHL NEIL | EVP Research and Development | 05 Aug 2022 | Sale | 521 | 618.27 | 322,119 | D |
08 Aug 2022 16:11 | REGN | REGENERON PHARMACEUTICALS Inc | STAHL NEIL | EVP Research and Development | 05 Aug 2022 | Sale | 424 | 617.43 | 261,790 | D |
08 Aug 2022 16:11 | REGN | REGENERON PHARMACEUTICALS Inc | STAHL NEIL | EVP Research and Development | 05 Aug 2022 | Sale | 535 | 616.4 | 329,774 | D |
08 Aug 2022 16:11 | REGN | REGENERON PHARMACEUTICALS Inc | STAHL NEIL | EVP Research and Development | 05 Aug 2022 | Sale | 1,610 | 615.49 | 990,939 | D |
08 Aug 2022 16:11 | REGN | REGENERON PHARMACEUTICALS Inc | STAHL NEIL | EVP Research and Development | 05 Aug 2022 | Sale | 4,112 | 614.35 | 2,526,207 | D |
08 Aug 2022 16:11 | REGN | REGENERON PHARMACEUTICALS Inc | STAHL NEIL | EVP Research and Development | 05 Aug 2022 | Sale | 3,218 | 613.49 | 1,974,211 | D |
08 Aug 2022 16:11 | REGN | REGENERON PHARMACEUTICALS Inc | STAHL NEIL | EVP Research and Development | 05 Aug 2022 | Sale | 2,076 | 612.43 | 1,271,405 | D |
08 Aug 2022 16:11 | REGN | REGENERON PHARMACEUTICALS Inc | STAHL NEIL | EVP Research and Development | 05 Aug 2022 | Sale | 2,022 | 611.44 | 1,236,332 | D |
08 Aug 2022 16:11 | REGN | REGENERON PHARMACEUTICALS Inc | STAHL NEIL | EVP Research and Development | 05 Aug 2022 | Sale | 3,931 | 610.49 | 2,399,836 | D |
08 Aug 2022 16:11 | REGN | REGENERON PHARMACEUTICALS Inc | STAHL NEIL | EVP Research and Development | 05 Aug 2022 | Sale | 3,044 | 609.62 | 1,855,683 | D |
08 Aug 2022 16:11 | REGN | REGENERON PHARMACEUTICALS Inc | STAHL NEIL | EVP Research and Development | 05 Aug 2022 | Sale | 610 | 608.7 | 371,307 | D |
08 Aug 2022 16:11 | REGN | REGENERON PHARMACEUTICALS Inc | STAHL NEIL | EVP Research and Development | 05 Aug 2022 | Sale | 724 | 607.47 | 439,808 | D |
08 Aug 2022 16:11 | REGN | REGENERON PHARMACEUTICALS Inc | STAHL NEIL | EVP Research and Development | 05 Aug 2022 | Sale | 176 | 606.78 | 106,793 | D |
08 Aug 2022 16:12 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 04 Aug 2022 | Sale | 1,410 | 622.06 | 877,105 | D |
08 Aug 2022 16:12 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 04 Aug 2022 | Sale | 4,156 | 621.54 | 2,583,120 | D |
08 Aug 2022 16:12 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 04 Aug 2022 | Sale | 4,887 | 620.85 | 3,034,094 | D |
11 Aug 2022 16:09 | REGN | REGENERON PHARMACEUTICALS Inc | POON CHRISTINE A | Director | 09 Aug 2022 | Sale | 8,186 | 621.27 | 5,085,716 | D |
11 Aug 2022 16:09 | REGN | REGENERON PHARMACEUTICALS Inc | POON CHRISTINE A | Director | 09 Aug 2022 | Sale | 6,814 | 620.47 | 4,227,883 | D |
17 Aug 2022 16:04 | REGN | REGENERON PHARMACEUTICALS Inc | MURPHY ANDREW J | EVP Research | 16 Aug 2022 | Sale | 86 | 649.54 | 55,860 | D |
17 Aug 2022 16:04 | REGN | REGENERON PHARMACEUTICALS Inc | MURPHY ANDREW J | EVP Research | 16 Aug 2022 | Sale | 766 | 648.78 | 496,965 | D |
17 Aug 2022 16:04 | REGN | REGENERON PHARMACEUTICALS Inc | MURPHY ANDREW J | EVP Research | 16 Aug 2022 | Sale | 701 | 647.73 | 454,059 | D |
17 Aug 2022 16:04 | REGN | REGENERON PHARMACEUTICALS Inc | MURPHY ANDREW J | EVP Research | 16 Aug 2022 | Sale | 325 | 646.44 | 210,093 | D |
17 Aug 2022 16:04 | REGN | REGENERON PHARMACEUTICALS Inc | MURPHY ANDREW J | EVP Research | 16 Aug 2022 | Sale | 119 | 645.63 | 76,830 | D |
17 Aug 2022 16:04 | REGN | REGENERON PHARMACEUTICALS Inc | MURPHY ANDREW J | EVP Research | 16 Aug 2022 | Sale | 332 | 644.49 | 213,971 | D |
17 Aug 2022 16:04 | REGN | REGENERON PHARMACEUTICALS Inc | MURPHY ANDREW J | EVP Research | 16 Aug 2022 | Sale | 94 | 643.37 | 60,477 | D |
17 Aug 2022 16:04 | REGN | REGENERON PHARMACEUTICALS Inc | MURPHY ANDREW J | EVP Research | 16 Aug 2022 | Sale | 329 | 642.53 | 211,392 | D |
17 Aug 2022 16:04 | REGN | REGENERON PHARMACEUTICALS Inc | MURPHY ANDREW J | EVP Research | 16 Aug 2022 | Sale | 537 | 641.47 | 344,469 | D |
17 Aug 2022 16:04 | REGN | REGENERON PHARMACEUTICALS Inc | MURPHY ANDREW J | EVP Research | 16 Aug 2022 | Sale | 148 | 640.91 | 94,855 | D |
17 Aug 2022 16:04 | REGN | REGENERON PHARMACEUTICALS Inc | MURPHY ANDREW J | EVP Research | 16 Aug 2022 | Sale | 76 | 639.85 | 48,629 | D |
02 Sep 2022 16:07 | REGN | REGENERON PHARMACEUTICALS Inc | MCCOURT MARION | EVP Commercial | 01 Sep 2022 | Sale | 1,100 | 577.62 | 635,382 | D |
08 Sep 2022 16:06 | REGN | REGENERON PHARMACEUTICALS Inc | COLES N ANTHONY | Director | 06 Sep 2022 | Sale | 602 | 584.57 | 351,911 | D |
08 Sep 2022 16:06 | REGN | REGENERON PHARMACEUTICALS Inc | COLES N ANTHONY | Director | 06 Sep 2022 | Sale | 1,045 | 583.16 | 609,402 | D |
08 Sep 2022 16:06 | REGN | REGENERON PHARMACEUTICALS Inc | COLES N ANTHONY | Director | 06 Sep 2022 | Sale | 1,220 | 582.56 | 710,723 | D |
08 Sep 2022 16:06 | REGN | REGENERON PHARMACEUTICALS Inc | COLES N ANTHONY | Director | 06 Sep 2022 | Sale | 822 | 581.44 | 477,944 | D |
08 Sep 2022 16:06 | REGN | REGENERON PHARMACEUTICALS Inc | COLES N ANTHONY | Director | 06 Sep 2022 | Sale | 688 | 580.44 | 399,343 | D |
08 Sep 2022 16:06 | REGN | REGENERON PHARMACEUTICALS Inc | COLES N ANTHONY | Director | 06 Sep 2022 | Sale | 550 | 579.85 | 318,918 | D |
08 Sep 2022 16:06 | REGN | REGENERON PHARMACEUTICALS Inc | COLES N ANTHONY | Director | 06 Sep 2022 | Sale | 273 | 578.25 | 157,862 | D |
08 Sep 2022 16:06 | REGN | REGENERON PHARMACEUTICALS Inc | COLES N ANTHONY | Director | 06 Sep 2022 | Sale | 500 | 577.07 | 288,535 | D |
08 Sep 2022 16:06 | REGN | REGENERON PHARMACEUTICALS Inc | COLES N ANTHONY | Director | 06 Sep 2022 | Sale | 300 | 576.73 | 173,019 | D |
08 Sep 2022 16:07 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 06 Sep 2022 | Sale | 3 | 587.23 | 1,762 | D |
08 Sep 2022 16:07 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 06 Sep 2022 | Sale | 8 | 586.31 | 4,690 | D |
08 Sep 2022 16:07 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 06 Sep 2022 | Sale | 16 | 585.58 | 9,369 | D |
08 Sep 2022 16:07 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 06 Sep 2022 | Sale | 6 | 584.77 | 3,509 | D |
08 Sep 2022 16:07 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 06 Sep 2022 | Sale | 11 | 583.45 | 6,418 | D |
08 Sep 2022 16:07 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 06 Sep 2022 | Sale | 8 | 582.51 | 4,660 | D |
08 Sep 2022 16:07 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 06 Sep 2022 | Sale | 14 | 581.46 | 8,140 | D |
08 Sep 2022 16:07 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 06 Sep 2022 | Sale | 9 | 580.75 | 5,227 | D |
08 Sep 2022 16:07 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 06 Sep 2022 | Sale | 7 | 579.67 | 4,058 | D |
08 Sep 2022 16:07 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 06 Sep 2022 | Sale | 11 | 578.56 | 6,364 | D |
08 Sep 2022 16:07 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 06 Sep 2022 | Sale | 4 | 577.26 | 2,309 | D |
08 Sep 2022 16:07 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 06 Sep 2022 | Sale | 3 | 576.85 | 1,731 | D |
12 Sep 2022 16:31 | REGN | REGENERON PHARMACEUTICALS Inc | BASSLER BONNIE L | Director | 09 Sep 2022 | Sale | 609 | 741 | 451,269 | D |
12 Sep 2022 16:31 | REGN | REGENERON PHARMACEUTICALS Inc | BASSLER BONNIE L | Director | 08 Sep 2022 | Sale | 1,279 | 686.99 | 878,660 | D |
12 Sep 2022 16:31 | REGN | REGENERON PHARMACEUTICALS Inc | BASSLER BONNIE L | Director | 08 Sep 2022 | Sale | 1,279 | 705 | 901,695 | D |
13 Sep 2022 16:04 | REGN | REGENERON PHARMACEUTICALS Inc | VAN PLEW DANIEL P | EVP & General Mgr, Industrial | 12 Sep 2022 | Sale | 79 | 722.83 | 57,104 | D |
13 Sep 2022 16:04 | REGN | REGENERON PHARMACEUTICALS Inc | VAN PLEW DANIEL P | EVP & General Mgr, Industrial | 12 Sep 2022 | Sale | 174 | 721.38 | 125,520 | D |
13 Sep 2022 16:04 | REGN | REGENERON PHARMACEUTICALS Inc | VAN PLEW DANIEL P | EVP & General Mgr, Industrial | 12 Sep 2022 | Sale | 181 | 720.41 | 130,394 | D |
13 Sep 2022 16:04 | REGN | REGENERON PHARMACEUTICALS Inc | VAN PLEW DANIEL P | EVP & General Mgr, Industrial | 12 Sep 2022 | Sale | 159 | 719.72 | 114,435 | D |
13 Sep 2022 16:04 | REGN | REGENERON PHARMACEUTICALS Inc | VAN PLEW DANIEL P | EVP & General Mgr, Industrial | 12 Sep 2022 | Sale | 435 | 718.5 | 312,548 | D |
13 Sep 2022 16:04 | REGN | REGENERON PHARMACEUTICALS Inc | VAN PLEW DANIEL P | EVP & General Mgr, Industrial | 12 Sep 2022 | Sale | 647 | 717.59 | 464,281 | D |
13 Sep 2022 16:04 | REGN | REGENERON PHARMACEUTICALS Inc | VAN PLEW DANIEL P | EVP & General Mgr, Industrial | 12 Sep 2022 | Sale | 1,052 | 716.28 | 753,527 | D |
13 Sep 2022 16:04 | REGN | REGENERON PHARMACEUTICALS Inc | VAN PLEW DANIEL P | EVP & General Mgr, Industrial | 12 Sep 2022 | Sale | 861 | 715.39 | 615,951 | D |
13 Sep 2022 16:04 | REGN | REGENERON PHARMACEUTICALS Inc | VAN PLEW DANIEL P | EVP & General Mgr, Industrial | 12 Sep 2022 | Sale | 267 | 714.42 | 190,750 | D |
13 Sep 2022 16:04 | REGN | REGENERON PHARMACEUTICALS Inc | VAN PLEW DANIEL P | EVP & General Mgr, Industrial | 12 Sep 2022 | Sale | 572 | 713.67 | 408,219 | D |
13 Sep 2022 16:04 | REGN | REGENERON PHARMACEUTICALS Inc | VAN PLEW DANIEL P | EVP & General Mgr, Industrial | 12 Sep 2022 | Sale | 110 | 712.44 | 78,368 | D |
13 Sep 2022 16:04 | REGN | REGENERON PHARMACEUTICALS Inc | VAN PLEW DANIEL P | EVP & General Mgr, Industrial | 12 Sep 2022 | Sale | 70 | 711.85 | 49,830 | D |
13 Sep 2022 16:04 | REGN | REGENERON PHARMACEUTICALS Inc | VAN PLEW DANIEL P | EVP & General Mgr, Industrial | 12 Sep 2022 | Sale | 2 | 710.25 | 1,420 | D |
13 Sep 2022 16:04 | REGN | REGENERON PHARMACEUTICALS Inc | VAN PLEW DANIEL P | EVP & General Mgr, Industrial | 12 Sep 2022 | Sale | 87 | 709.93 | 61,764 | D |
03 Oct 2022 16:05 | REGN | REGENERON PHARMACEUTICALS Inc | TESSIER-LAVIGNE MARC | Director | 03 Oct 2022 | Sale | 3,612 | 718 | 2,593,416 | D |
03 Oct 2022 16:05 | REGN | REGENERON PHARMACEUTICALS Inc | TESSIER-LAVIGNE MARC | Director | 30 Sep 2022 | Sale | 3,428 | 698 | 2,392,744 | D |
03 Oct 2022 16:05 | REGN | REGENERON PHARMACEUTICALS Inc | TESSIER-LAVIGNE MARC | Director | 29 Sep 2022 | Sale | 20 | 704.83 | 14,097 | D |
03 Oct 2022 16:05 | REGN | REGENERON PHARMACEUTICALS Inc | TESSIER-LAVIGNE MARC | Director | 29 Sep 2022 | Sale | 16 | 702.36 | 11,238 | D |
03 Oct 2022 16:05 | REGN | REGENERON PHARMACEUTICALS Inc | TESSIER-LAVIGNE MARC | Director | 29 Sep 2022 | Sale | 80 | 699.82 | 55,986 | D |
03 Oct 2022 16:05 | REGN | REGENERON PHARMACEUTICALS Inc | TESSIER-LAVIGNE MARC | Director | 29 Sep 2022 | Sale | 208 | 698.44 | 145,276 | D |
03 Oct 2022 16:05 | REGN | REGENERON PHARMACEUTICALS Inc | TESSIER-LAVIGNE MARC | Director | 29 Sep 2022 | Sale | 160 | 697.29 | 111,566 | D |
03 Oct 2022 16:05 | REGN | REGENERON PHARMACEUTICALS Inc | TESSIER-LAVIGNE MARC | Director | 29 Sep 2022 | Sale | 85 | 696.13 | 59,171 | D |
03 Oct 2022 16:05 | REGN | REGENERON PHARMACEUTICALS Inc | TESSIER-LAVIGNE MARC | Director | 29 Sep 2022 | Sale | 554 | 691.59 | 383,141 | D |
03 Oct 2022 16:05 | REGN | REGENERON PHARMACEUTICALS Inc | TESSIER-LAVIGNE MARC | Director | 29 Sep 2022 | Sale | 692 | 690.65 | 477,930 | D |
03 Oct 2022 16:05 | REGN | REGENERON PHARMACEUTICALS Inc | TESSIER-LAVIGNE MARC | Director | 29 Sep 2022 | Sale | 1,009 | 689.56 | 695,766 | D |
03 Oct 2022 16:05 | REGN | REGENERON PHARMACEUTICALS Inc | TESSIER-LAVIGNE MARC | Director | 29 Sep 2022 | Sale | 637 | 688.71 | 438,708 | D |
03 Oct 2022 16:05 | REGN | REGENERON PHARMACEUTICALS Inc | TESSIER-LAVIGNE MARC | Director | 29 Sep 2022 | Sale | 321 | 687.9 | 220,816 | D |
03 Oct 2022 16:05 | REGN | REGENERON PHARMACEUTICALS Inc | TESSIER-LAVIGNE MARC | Director | 29 Sep 2022 | Sale | 16 | 686.89 | 10,990 | D |
05 Oct 2022 16:10 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 03 Oct 2022 | Sale | 24 | 733.64 | 17,607 | D |
05 Oct 2022 16:10 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 03 Oct 2022 | Sale | 7 | 732.47 | 5,127 | D |
05 Oct 2022 16:10 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 03 Oct 2022 | Sale | 6 | 731.49 | 4,389 | D |
05 Oct 2022 16:10 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 03 Oct 2022 | Sale | 2 | 730 | 1,460 | D |
05 Oct 2022 16:10 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 03 Oct 2022 | Sale | 19 | 728.23 | 13,836 | D |
05 Oct 2022 16:10 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 03 Oct 2022 | Sale | 18 | 727.52 | 13,095 | D |
05 Oct 2022 16:10 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 03 Oct 2022 | Sale | 1 | 726.03 | 726 | D |
05 Oct 2022 16:10 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 03 Oct 2022 | Sale | 3 | 718.48 | 2,155 | D |
05 Oct 2022 16:10 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 03 Oct 2022 | Sale | 2 | 717.87 | 1,436 | D |
05 Oct 2022 16:10 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 03 Oct 2022 | Sale | 6 | 715.94 | 4,296 | D |
05 Oct 2022 16:10 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 03 Oct 2022 | Sale | 2 | 714.08 | 1,428 | D |
05 Oct 2022 16:10 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 03 Oct 2022 | Sale | 5 | 711 | 3,555 | D |
05 Oct 2022 16:10 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 03 Oct 2022 | Sale | 3 | 710.73 | 2,132 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)